Anti-Pot Activists May Care Too Much About the Prescription Drug Industry’s Health

Anti-Pot Activists May Care Too Much About the Prescription Drug Industry’s Health

Anti-Pot Activists May Care Too Much About the Prescription Drug Industry’s Health

Lee Fang and Chris Hayes discuss the true motivation behind anti-pot campaigns. 

Copy Link
Facebook
X (Twitter)
Bluesky
Pocket
Email

Why is so much of the funding for anti-marijuana activist organizations coming from pharmaceutical companies? Joining Chris Hayes on All In last night, Lee Fang explained the tangled links between big pharma companies who make opioid prescription drugs and anti-legalization activist groups that he uncovered while reporting his article, “The Real Reason Pot Is Still Illegal.”

According to Fang, the anti-drug activists who focus on pot have their priorities misplaced, as prescription painkiller abuse is an “epidemic” that is sweeping the country. “The CDC says it kills over 16,000 people a year,” Fang told Hayes.
Hannah Harris Green

Your support makes stories like this possible

From illegal war on Iran to an inhumane fuel blockade of Cuba, from AI weapons to crypto corruption, this is a time of staggering chaos, cruelty, and violence. 

Unlike other publications that parrot the views of authoritarians, billionaires, and corporations, The Nation publishes stories that hold the powerful to account and center the communities too often denied a voice in the national media—stories like the one you’ve just read.

Each day, our journalism cuts through lies and distortions, contextualizes the developments reshaping politics around the globe, and advances progressive ideas that oxygenate our movements and instigate change in the halls of power. 

This independent journalism is only possible with the support of our readers. If you want to see more urgent coverage like this, please donate to The Nation today.

Ad Policy
x